TAVR (VitaFlow) in Patients with Severe Aortic Regurgitation Using a Novel Anatomical Classification and Dual Anchoring Theory: 30-Day Results from the AURORA Trial

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker's Bureau - Highlife; Medtronic; Abbott; Philips; Peijia